Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateTimeSourceHeadlineSymbolCompany
11/04/202422:00Business WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
08/04/202422:00Business WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
15/02/202009:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
15/02/202008:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
15/02/202008:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
12/02/202008:41Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
06/02/202003:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
28/01/202001:38Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
21/01/202022:00Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
04/12/201911:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
03/12/201910:01Business WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
27/11/201908:01Business WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
13/11/201909:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
13/11/201904:13Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
08/11/201909:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
08/11/201908:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
08/11/201908:01Business WireAudentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
31/10/201922:00Business WireAudentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...NASDAQ:BOLDBoundless Bio Inc
09/10/201921:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
05/10/201921:01Business WireAudentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...NASDAQ:BOLDBoundless Bio Inc
05/10/201908:00Business WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
01/10/201922:00Business WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
30/09/201922:00Business WireAudentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...NASDAQ:BOLDBoundless Bio Inc
26/09/201908:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
17/09/201906:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
10/09/201906:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
10/09/201906:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
10/09/201906:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
07/09/201908:00Business WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD